No Detail Found!

Etiological differences in lyme borreliosis patients with and without localized scleroderma based on serological examination in the western ukraine

Author(s)
Mykhaylo Andreychyn Department of Infectious Diseases with Epidemiology, Dermatology and Venereology, I. Horbachevskyy Ternopil National Medical University,19 Hlyboka street, Ternopil, 46001,Ukraine
Mykhaylo Korda Department of Medical Biochemistry, I. Horbachevskyy Ternopil National Medical University, 1 Maidan Voli, Ternopil, 46001, Ukraine
Maria Shkilna Department of Infectious Diseases with Epidemiology, Dermatology and Venereology, I. Horbachevskyy Ternopil National Medical University,19 Hlyboka street, Ternopil, 46001,Ukraine
Oleksandr Tokarskyy Department of Medical Biochemistry, I. Horbachevskyy Ternopil National Medical University, 1 Maidan Voli, Ternopil, 46001, Ukraine
Kateryna Shtokailo Department of Infectious Diseases with Epidemiology, Dermatology and Venereology, I. Horbachevskyy Ternopil National Medical University,19 Hlyboka street, Ternopil, 46001,Ukraine
Tetiana Yuzkiv Department of Infectious Diseases with Epidemiology, Dermatology and Venereology, I. Horbachevskyy Ternopil National Medical University,19 Hlyboka street, Ternopil, 46001,Ukraine
Abstract
Background Possible associations of localized scleroderma (LS) with Lyme borreliosis (LB) were reported in certain countries, though denied in others. Therefore, it is still under investigation, whether the association is real or fictional. Objective The aims of the current study was to determine percentage of serologically positive patients among suspected LB patients, as well as to investigate etiological differences between confirmed LB patients with and without LS in Ternopil region. Methods An observational study of 196 patients with complaints related to LB treated at Ternopil healthcare institutions (2017-2022) was conducted. LB serological confirmation was done using two-stage procedure (ELISA and immunoblotting). The confirmed LB patients were split into two groups, with or without localized scleroderma (LS), and a wide spectra of specific IgG were analyzed to check for significant differences between the two groups. Results We confirmed the necessity of the two-stage procedure, as some ELISA screening results, 11.4% (95% CI 3.1-29.3) for IgM and 11.5% (95% CI 4.6-23.6) for IgG, appeared to be false positives during stage two immunoblotting tests. VlsE antigens of B. afzelii and p83 were significantly more often detected in the LB patients with LS compared to LB patients without LS, p < 0.05. VlsE antigens of B. burgdorferi s.s. and p39 were diagnosed more often in LB alone patients compared to LB with LS patients, p <0.05. Conclusion We can speculate, that failures to detect borreliosis-associated morphea in some countries may be related to the absence of B. afzelii in those areas.
Publication Details
Page(s) 372-380
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 33, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
localized scleroderma, Borrelia afzelii, eol&gt;Lyme borreliosis
0

Citations

0

Downloads

44

Views